Saturday, July 11, 2026

pharma · Type 2 Diabetes Mellitus (T2DM)

Gan & Lee

Gan & Lee clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
1998 Founded
494 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Founded
1998
Employees
494
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Gan & Lee projects

1 ClinicalTrials.gov programs sponsored by Gan & Lee.

Gan & Lee has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. GZR102

    Gan & Lee Pharmaceuticals.

    Type 2 Diabetes Mellitus (T2DM)

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Gan & Lee have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.